
Mettler-Toledo International, Inc.: stock overview
Price
$1,738.91
November 13, 2026Market cap $35.3B
What Ploutos Investor adds for Mettler-Toledo International
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from 2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- A figure that did not match the numbers it is built from has been left out.
In short
Mettler-Toledo International had revenue of $4.2B over the last 12 months and net income of $934M, a net margin of 22.3%. Revenue grew by 5.5% a year on average over the last 5 years. At $1,738.91 the shares trade at a P/E of 37.8, against a median of 33.8 over the last 5 fiscal years. It has net debt of $2.0B. It pays no dividend.
From its SEC filings (latest fiscal year to December 31, 2025) and the price of November 13, 2026.
Its SEC filings- Market cap
- $35.3B
- 20.33M shares
- P/E
- 37.8
- Today37.8Median33.8
- Revenue, 12 months
- $4.2B
- +5.5% a year over 5 years
- Net margin
- 22.3%
- 2025: 21.6%, above 92% of its industry
Worth knowing
What a holder would want to hear from the company's SEC filings of the last three years. Each with its filing, without comment.
3 fiscal years in figures
Each fiscal year's figures as the company filed them, and the share price at its end.
+3.1% a year over 2 years
Fiscal years in figures
MTD's revenue, profit, cash flow and dividend with each year-end price, from 2009 to 2022, 14 more fiscal years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 5 fiscal years.
Key figures
The company's current figures in five groups. Each term is explained behind its ⓘ.
Valuation
- Market cap 3-year median: $26.1B
- $35.3B
- Enterprise value
- $37.3B
- P/E 3-year median: 33.2
- 37.8
- EV / EBIT
- 33.1
- EV / Revenue
- 8.9
- P/B
- –
- FCF yield 3-year median: 3.3%
- 2.5%
- Earnings yield 3-year median: 3.0%
- 2.6%
Profitability
- Gross margin
- 60.4%
- Net margin 3-year median: 21.6%
- 22.3%
- ROIC
- 44.5%
- ROIC, 5-year average
- 40.8%
- ROE
- –
Growth
- Revenue, yearly change
- +4.0%
- EPS, yearly change
- +3.9%
- FCF, yearly change
- -1.8%
- Revenue, average a year
- +5.5%
- EPS, average a year
- +11.0%
The yearly change compares FY2025 with FY2024.
Balance sheet
- Cash
- $52M
- Total debt
- $2.0B
- Net debt
- $2.0B
- Net debt / EBITDA
- 1.7x
- Interest cover
- 16.8x
- Current ratio
- 1.10
Balance sheet of September 30, 2026.
Returns to shareholders
- Dividend yield
- 0.00%
- Buybacks
- 2.26%
- Total returned
- 2.26%
- Shares, yearly change
- -2.8%
Against its industry
Where its margins and returns stood in fiscal 2025 among the SEC filers of its industry (SIC code 38).
Gross margin
59.4%
Above 56% of the 161 companies in its industry, and 78% of all.
Net margin
21.6%
Above 92% of the 189 companies in its industry, and 84% of all.
ROA
23.4%
Above 97% of the 190 companies in its industry, and 98% of all.
Revenue growth
4.0%
Above 37% of the 186 companies in its industry, and 42% of all.
From the yearly figures every company files with the SEC, for those with revenue of at least $25 million. The industry is the first two digits of the SIC code.
The company at the SEC
How it is registered and when its fiscal year ends.
- Name at the SEC
- METTLER TOLEDO INTERNATIONAL INC/
- CIK
- 1037646
- Exchange
- NYSE
- Industry (SIC)
- 3826 · Laboratory Analytical Instruments
- Fiscal year ends
- December 31
- Latest annual report
- December 31, 2025
- Reporting currency
- USD
- Shares
- 20.33M
Other companies: Healthcare
The largest companies of the same sector, each with its own page.
- LLYEli Lilly and Company+0,00%Compare with MTD
- JNJJohnson & Johnson+0,00%Compare with MTD
- ABBVAbbVie+0,00%Compare with MTD
- UNHUnitedHealth+0,00%Compare with MTD
- MRKMerck & Company+0,00%Compare with MTD
- AMGNAmgen+0,00%Compare with MTD
- TMOThermo Fisher Scientific+0,00%Compare with MTD
- ABTAbbott Laboratories+0,00%Compare with MTD
The full analysis
What do Mettler-Toledo International's filings show?
These are Mettler-Toledo International's figures. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
What is MTD's market cap?
Mettler-Toledo International, Inc.'s market cap is $35.3B, at a price of $1,738.91 on November 13, 2026 and 20.33M shares.
What is MTD's P/E?
MTD's P/E is 37.8, on earnings per share of $46.10 over the last 12 months. The median over the last 5 fiscal years was 33.8.
How much revenue does MTD have?
Mettler-Toledo International had revenue of $4.2B over the last 12 months. Over the last 5 years it changed by +5.5% a year on average.
Does MTD pay a dividend?
No. Mettler-Toledo International paid no regular dividend over the last 12 months.
Where do the figures come from?
From Mettler-Toledo International, Inc.'s SEC filings (10-K and 10-Q) and the share price. They hold no analyst estimates and no score, and they are not a recommendation.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.